Breast Surgery Preconditioning Devices

Plexāā Secures Funding for its BLOOM⁴³ Device

Plexāā has successfully secured an additional $4.5 million in funding to accelerate the upcoming U.S. launch of its groundbreaking medical innovation, BLOOM⁴³. Serving as the world’s first fully wearable medical device for patients preparing for breast cancer surgery and reconstruction, BLOOM⁴³ utilizes Supraphysiological PreconditioningÔ, a novel therapeutic technique that applies safe, intermittent thermal stimulation to the skin.

Through this targeted approach, the body triggers the release of heat-shock proteins, which promote vasodilation and increased blood flow to the surgical site. Early proof-of-concept clinical trials have shown this process to significantly reduce post-surgical wound healing complications, offering a proactive step in optimizing outcomes.

Paired with its companion BLOOM⁴³ mobile app, the device supports a comprehensive PrehabilitationÔ strategy—a patient-centric approach that emphasizes surgical readiness through non-invasive, preoperative intervention. Interested consumers can learn more about BLOOM⁴³ through the company's dedicated website.

Image Credit: Plex??

Wearable Medical Devices
The BLOOM⁴³ device exemplifies the potential of wearable technology to revolutionize pre-surgical treatment through personal and continuous health monitoring.
Prehabilitation Techniques
Supraphysiological PreconditioningÔ in the BLOOM⁴³ device showcases a shift towards enhancing surgical outcomes by preparing patients physically and physiologically before surgery.
Thermal Stimulation Therapy
The use of intermittent thermal stimulation in the BLOOM⁴³ device indicates a novel approach in therapeutic care that could redefine traditional pre-surgical preparation strategies.

Sectors Adopting This

Healthcare Technology
The introduction of the BLOOM⁴³ device into the market highlights a burgeoning sector focused on integrating cutting-edge tech solutions to improve patient care.
Medical Devices
Plexāā’s wearable BLOOM⁴³ device is set to disrupt conventional pre-surgical care, forging new pathways in the development of devices aimed at enhancing surgical outcomes.
Digital Health Platforms
The BLOOM⁴³ mobile app, as a companion to the wearable device, emphasizes the growing impact of digital platforms in delivering comprehensive and personalized healthcare solutions.
SCORE
5.3 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 44%
Activity 58%
Freshness 56%

Solutions for innovators working at the edge of change. We help transform emerging ideas into practical, durable solutions by combining strategic thinking, creative exploration, and hands-on execution.

Trends © 2026 Trend Hunter Inc. All Rights Reserved.
LinkedIn Instagram X